4 December 2020

The December edition of Oncode’s digital magazine is here

Welcome to the last 2020 issue of Oncode’s digital magazine. As this unusual year comes to an end, December is the month to look back and forward.

Vesna de Jong

This issue brings some good news (no spoiler alert, you must read our Editorial), and we hope will also tap into your interests, curiosity and need of reflection.

In our Dialogue section Leila Akkari and Jeanine Roodhart look back at the past months, reflecting on their experiences and the challenges they faced. Oncode Investigator Jarno Drost didn’t always dream of becoming a researcher - after the Dialogue, read further for a chance to get to know him a bit better.

This issue we would also like to make an introduction: Alain Kummer, our new managing director as of last September talks about his new role and about his ambitions in the magazine’s new column section.

Finally, take a deep dive into the work of Oncode Investigator Sylvie Noordermeer, who imitates cancer cells in the lab by inflicting DNA damage, finding new targets for more effective treatments.

All this and much more is just a single click away. Feel free to share our stories and let us know what you think: we like to hear from you!

Click here to open the magazine

You can subscribe to our magazine here.

Other News

Oncode Coverbeeld Q2 2021
Oncode Digital Magazine - April 2021
Welcome to the April edition of our digital magazine! Discover the latest interviews, science stories, latest updates and much more.
Vesnade Jong

<span>Vesna</span><span>de Jong</span>

Vesna is a Digital Content Manager at Lygature, and is responsible for all things digital at Oncode. Originally from Slovenia, where she finished her MA in English language and literature, life led her to the Netherlands. Vesna has more than 10 years of experience in translation and localization, and has gained extensive experience of digital communications while working for one of the biggest online travel agencies.
Lude and Michiel
Oncode Investigators Michiel Vermeulen and Lude Franke receive Vici grant
Oncode is proud to announce that Oncode Investigators Michiel Vermeulen (Radboudumc) and Lude Franke (UMCG) will both receive the Vici grant of 1.5 million euros from the Dutch Research Council (NWO).
Ecto org KRT14
First patient-derived organoid model for cervical cancer
Researchers from the group of Oncode Investigator Hans Clevers (Hubrecht Institute) developed the first patient-derived organoid model for cervical cancer. They also modelled the healthy human cervix using organoids. In close collaboration with the UMC Utrecht, Princess Máxima Center for pediatric oncology and the Netherlands Cancer Institute, the researchers used the organoid-based platform to study sexually transmitted infections for a herpes virus. The model can potentially also be used to study the human papillomavirus (HPV), which is one of the main causes of cervical cancer.